Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001916048-26-000012

Chief Commercial Officer sold 7,437 shares at $25.98 ($193,189)

  • Chief Commercial Officer acquired 7,437 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Warren Eric Chief Commercial Officer 2026-08-21 Option exercise 10b5-1 +7,437 $13.24 $98,466 45,837 D: show line 1 in the form
Warren Eric Chief Commercial Officer 2026-08-21 Sale 10b5-1 −7,437 $25.98 $193,189 38,400 D: show line 2 in the form
Open-market sales · 7,437 sh · avg $25.98 · $193,189

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Warren Eric Chief Commercial Officer 2026-08-21 Option exercise · Stock Option 10b5-1 −7,437 238,001 D: show line 3 in the form
Loading xslF345X06/wk-form4_1787692603.xml…